Emerald Investment Advisers LLC bought a new position in shares of Palomar Holdings, Inc. (NASDAQ:PLMR – Free Report) during the 2nd quarter, HoldingsChannel.com reports. The fund bought 48,821 shares of the company’s stock, valued at approximately $6,170,000.
Other large investors have also bought and sold shares of the company. Geneos Wealth Management Inc. bought a new stake in Palomar in the fourth quarter valued at $32,000. Kestra Advisory Services LLC acquired a new position in shares of Palomar during the fourth quarter valued at about $33,000. Rockefeller Capital Management L.P. boosted its position in shares of Palomar by 81.5% during the 4th quarter. Rockefeller Capital Management L.P. now owns 294 shares of the company’s stock worth $40,000 after purchasing an additional 132 shares in the last quarter. Frazier Financial Advisors LLC bought a new position in shares of Palomar during the 2nd quarter worth about $51,000. Finally, Parallel Advisors LLC grew its stake in shares of Palomar by 638.3% in the 1st quarter. Parallel Advisors LLC now owns 443 shares of the company’s stock valued at $53,000 after buying an additional 383 shares during the period. 90.25% of the stock is currently owned by institutional investors and hedge funds.
Palomar Stock Performance
Shares of PLMR opened at $130.09 on Friday. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.50 and a current ratio of 0.50. The stock has a 50 day moving average price of $130.76 and a two-hundred day moving average price of $123.92. The firm has a market capitalization of $3.42 billion, a P/E ratio of 17.49 and a beta of 0.40. Palomar Holdings, Inc. has a 52 week low of $100.81 and a 52 week high of $147.62.
Palomar Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 2nd. Shareholders of record on Wednesday, August 19th will be issued a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date of this dividend is Wednesday, August 19th. Palomar’s payout ratio is currently 24.19%.
Wall Street Analysts Forecast Growth
A number of brokerages recently commented on PLMR. JPMorgan Chase & Co. boosted their target price on Palomar from $150.00 to $167.00 and gave the company an “overweight” rating in a research report on Monday, July 20th. Weiss Ratings upgraded Palomar from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, June 18th. Piper Sandler raised their price objective on Palomar from $132.00 to $165.00 and gave the company an “overweight” rating in a research note on Wednesday, July 15th. Zacks Research downgraded Palomar from a “strong-buy” rating to a “hold” rating in a report on Friday, May 15th. Finally, Evercore set a $152.00 price objective on Palomar in a report on Friday, July 10th. Four equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $162.75.
Read Our Latest Research Report on Palomar
More Palomar News
Here are the key news stories impacting Palomar this week:
- Positive Sentiment: Strong premium growth and expansion in specialty insurance are expected to support Palomar’s earnings momentum. Analysts’ average price target of $162.75 and recent target increases reinforce the bullish view. Can Strong Premium Growth Sustain Palomar’s Earnings Momentum?
- Positive Sentiment: Dowling & Partners expressed a positive view of Palomar’s fiscal 2026 earnings outlook, adding to expectations for continued profit growth. DOWLING & PARTN Has Positive View of Palomar FY2026 Earnings
- Positive Sentiment: Palomar’s latest quarterly results provide fundamental support: earnings per share of $2.36 exceeded the $2.19 consensus estimate, while profitability and return on equity remained strong.
- Neutral Sentiment: Several insiders, including the president, CFO and Jonathan Knutzen, sold relatively small portions of their holdings to cover tax withholding on vested equity awards. Because the transactions were not discretionary sales, they are less negative than typical insider selling, though they may limit near-term sentiment.
- Neutral Sentiment: Palomar declared a quarterly dividend of $0.45, equivalent to $1.80 annually and a yield of approximately 1.4%, providing modest shareholder support.
- Negative Sentiment: Competitive pricing could reduce premium profitability, while a higher combined ratio would pressure underwriting margins. These risks may temper the market’s response to otherwise strong growth expectations. Can Strong Premium Growth Sustain Palomar’s Earnings Momentum?
Insider Activity
In other news, CEO Mac Armstrong sold 3,500 shares of the company’s stock in a transaction on Monday, June 22nd. The shares were sold at an average price of $112.96, for a total value of $395,360.00. Following the completion of the sale, the chief executive officer owned 329,388 shares in the company, valued at $37,207,668.48. This represents a 1.05% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Rodolphe Herve sold 1,207 shares of the firm’s stock in a transaction dated Friday, July 31st. The shares were sold at an average price of $135.35, for a total transaction of $163,367.45. Following the transaction, the chief operating officer directly owned 3,548 shares in the company, valued at $480,221.80. The trade was a 25.38% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders sold 20,165 shares of company stock worth $2,680,993. Company insiders own 3.70% of the company’s stock.
Palomar Company Profile
Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.
In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.
Featured Stories
- Five stocks we like better than Palomar
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Want to see what other hedge funds are holding PLMR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Palomar Holdings, Inc. (NASDAQ:PLMR – Free Report).
Receive News & Ratings for Palomar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palomar and related companies with MarketBeat.com's FREE daily email newsletter.
